Understanding the Opioid Epidemic
Surgeon General’s Report Facing Addiction in America — November 2016
HarvardX- edX —Online course (FREE)
“The Opioid Crisis in America”
The Opioid Epidemic in Massachusetts: A Data Visualization of the Findings of the Chapter 55 Report
Opioid Prescribing Guidelines
MA Prescribing Guidelines
Webinar – “Incorporating the New Prescribing Guidelines into Practice “ with Daniel Alford, MD, MPH
CDC Guidelines for Prescribing Opioids
Massachusetts Prescribing Laws
The Massachusetts 2016 Opioid Legislation
Massachusetts Opioid Prescribing Law – Signed into law, March 2016
“An Act Relative to Substance Use, Treatment Education and Prevention”
MMS Mass Legislation Practice Guide
2016 Legislation Fact Sheet - Please note additions from the 2018 MA Legislation regarding PMP change that Physicians
must utilize the prescription monitoring program each time prior to prescribing
to a patient a benzodiazepine.
The Massachusetts 2018 Opioid
Legislation
Governor Baker Signs Second Major Piece of Legislation to Address Opioid Epidemic in Massachusetts
Prescription Medication Laws in Massachusetts
Webinar — “Making Sense of Massachusetts Opioid Prescribing Laws and State and National Guidelines” Daniel Alford, MD, MPH
- When viewing this webinar please note the change in law, recent MA opioid legislation now requires that prescribers check the PMP each time a prescription is issued for a benzodiazepine. Previous law required prescribers to only check on first prescriptions.
Prescription Drug Monitoring Program — Using MassPAT
Massachusetts’s
law requires that physicians utilize the prescription-monitoring
program prior to prescribing to a patient a narcotic drug in Schedule II or III
and benzodiazepine each time. Physicians must also utilize the prescription
monitoring program prior to prescribing to a patient for the first time: any
controlled substance in Scheduled IV or V which the Department has designated
in guidance as a drug that is commonly abused and may lead to dependence.
Gabapentin has been designated as an additional drug for the purposes of
reporting to the PMP.
MassPAT
MassPAT Webinar: “Incorporating the New MassPAT into Your Practice” (FREE)
